| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Research Communications |
Laboratoire de Recherche sur la Croissance Cellulaire, la Régénération et la Réparation Tissulaires, Université Paris XII-Val de Marne, France UPRESA - CNRS 7053.
Ischemia and denervation of EDL muscle of adult rat induce a large central zone of degeneration surrounded by a thin zone of peripheral surviving muscle fibers. Muscle regeneration is a complex phenomenon in which many agents interact, such as growth factors and heparan sulfate components of the extracellular matrix. We have shown that synthetic polymers, called RGTA (as regenerating agents), which imitate the heparan sulfates, are able to stimulate tissue repair when applied at the site of injury. In crushed muscles, RGTA were found to accelerate both regeneration and reinnervation. In vitro, RGTA act as protectors and potentiators of various heparin binding growth factors (HBGF). It was postulated that in vivo their tissue repair properties were due in part to an increase of bioavailability of endogenously released HBGF. In the present work, we show that ischemic and denervated EDL muscle treated by a unique injection of RGTA differs from the control after 1 wk in several aspects: 1) the epimysial postinflammatory reaction is inhibited and the area of fibrotic tissue among fibers is reduced; 2) the peripheral zone, as measured by the number of intact muscle fibers, was increased by more than twofold; and 3) In the central zone, RGTA enhances the regeneration of the muscle fibers as well as muscle revascularization. These results suggest that RGTA both protects muscle fibers from degeneration and preserves the differentiated state of the surviving fibers. For the first time it is demonstrated that a functionalized polymeric compound can prevent some of the damage resulting from muscle ischemia. RGTA may therefore open a new therapeutic approach for muscle fibrosis and other postischemic muscle pathologies.—Desgranges, P., Barbaud, C., Caruelle, J.-P., Barritaoult, D., Gautron, J. A substituted dextran enhances muscle fiber survival and regeneration in ischemic and denervated rat EDL muscle.
Key Words: skeletal muscle • RGTA • ischemia
This article has been cited by other articles:
|
|
 |
|
  C. A. C. Ottenheijm, G. J. Jenniskens, M. C. P. Geraedts, T. Hafmans, L. M. A. Heunks, T. H. van Kuppevelt, and P. N. R. Dekhuijzen Diaphragm dysfunction in chronic obstructive pulmonary disease: a role for heparan sulphate? Eur. Respir. J., July 1, 2007; 30(1): 80 - 89. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Larramendy-Gozalo, A. Barret, E. Daudigeos, E. Mathieu, L. Antonangeli, C. Riffet, E. Petit, D. Papy-Garcia, D. Barritault, P. Brown, et al. Comparison of CR36, a new heparan mimetic, and pentosan polysulfate in the treatment of prion diseases J. Gen. Virol., March 1, 2007; 88(3): 1062 - 1067. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. R Trevitt and J. Collinge A systematic review of prion therapeutics in experimental models Brain, September 1, 2006; 129(9): 2241 - 2265. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Rouet, Y. Hamma-Kourbali, E. Petit, P. Panagopoulou, P. Katsoris, D. Barritault, J.-P. Caruelle, and J. Courty A Synthetic Glycosaminoglycan Mimetic Binds Vascular Endothelial Growth Factor and Modulates Angiogenesis J. Biol. Chem., September 23, 2005; 280(38): 32792 - 32800. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Barret, L. Forestier, J.-P. Deslys, R. Julien, and P. F. Gallet Glycosylation-related Gene Expression in Prion Diseases: PrPSc ACCUMULATION IN SCRAPIE INFECTED GT1 CELLS DEPENDS ON {beta}-1,4-LINKED GalNAc-4-SO4 HYPOSULFATION J. Biol. Chem., March 18, 2005; 280(11): 10516 - 10523. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Barbosa, C. Morin, S. Garcia, A. Duchesnay, M. Oudghir, G. Jenniskens, H.-Q. Miao, S. Guimond, G. Carpentier, J. Cebrian, et al. A synthetic glycosaminoglycan mimetic (RGTA) modifies natural glycosaminoglycan species during myogenesis J. Cell Sci., January 1, 2005; 118(1): 253 - 264. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. C. Casar, C. Cabello-Verrugio, H. Olguin, R. Aldunate, N. C. Inestrosa, and E. Brandan Heparan sulfate proteoglycans are increased during skeletal muscle regeneration: requirement of syndecan-3 for successful fiber formation J. Cell Sci., January 1, 2004; 117(1): 73 - 84. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Pesce, A. Orlandi, M. G. Iachininoto, S. Straino, A. R. Torella, V. Rizzuti, G. Pompilio, G. Bonanno, G. Scambia, and M. C. Capogrossi Myoendothelial Differentiation of Human Umbilical Cord Blood-Derived Stem Cells in Ischemic Limb Tissues Circ. Res., September 5, 2003; 93 (5): e51 - e62. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. T. Adjou, S. Simoneau, N. Sales, F. Lamoury, D. Dormont, D. Papy-Garcia, D. Barritault, J.-P. Deslys, and C. I. Lasmezas A novel generation of heparan sulfate mimetics for the treatment of prion diseases J. Gen. Virol., September 1, 2003; 84(9): 2595 - 2603. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Q. ESCARTIN, C. LALLAM-LAROYE, B. BAROUKH, F. O. MORVAN, J. P. CARUELLE, G. GODEAU, D. BARRITAULT, and J. L. SAFFAR A new approach to treat tissue destruction in periodontitis with chemically modified dextran polymers FASEB J, April 1, 2003; 17(6): 644 - 651. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. E. Morgan, J. G. Gross, C. N. Pagel, J. R. Beauchamp, A. Fassati, A. J. Thrasher, J. P. Di Santo, I. B. Fisher, X. Shiwen, D. J. Abraham, et al. Myogenic cell proliferation and generation of a reversible tumorigenic phenotype are triggered by preirradiation of the recipient site J. Cell Biol., May 13, 2002; 157(4): 693 - 702. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Ledoux, D. Papy-Garcia, Q. Escartin, M.-A. Sagot, Y. Cao, D. Barritault, J. Courtois, W. Hornebeck, and J.-P. Caruelle Human Plasmin Enzymatic Activity Is Inhibited by Chemically Modified Dextrans J. Biol. Chem., September 15, 2000; 275(38): 29383 - 29390. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
